Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekert

Showing results (451-460 of 492) with videos related to

Pageof 50
Sort By:
Stem Cell Reports|July 3, 2024
Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibilityDavid Pamies, Jason Ekert, Marie-Gabrielle Zurich, et al.
Blood Advances|March 10, 2020
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemiaLauren M Brown, Andrew Lonsdale, Andrea Zhu, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
Cold Spring Harbor Molecular Case Studies|November 4, 2020
Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumorsDong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, et al.
Blood|September 30, 2022
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertionsGeorgina L Ryland, Masayuki Umeda, Linda Holmfeldt, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Frontiers in Oncology|March 20, 2023
<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymomaJacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, et al.
Science Translational Medicine|May 20, 2016
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemiaGabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
Nature|June 17, 2020
Entanglement-based secure quantum cryptography over 1,120 kilometresJuan Yin, Yu-Huai Li, Sheng-Kai Liao, et al.
Pageof 50

Showing results (451-460 of 492) with videos related to

Sort By:
Pageof 50
Stem Cell Reports|July 3, 2024
Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibilityDavid Pamies, Jason Ekert, Marie-Gabrielle Zurich, et al.
Blood Advances|March 10, 2020
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemiaLauren M Brown, Andrew Lonsdale, Andrea Zhu, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
Cold Spring Harbor Molecular Case Studies|November 4, 2020
Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumorsDong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, et al.
Blood|September 30, 2022
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertionsGeorgina L Ryland, Masayuki Umeda, Linda Holmfeldt, et al.
Scientific Reports|March 7, 2023
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genesPamela Ajuyah, Chelsea Mayoh, Loretta M S Lau, et al.
Frontiers in Oncology|March 20, 2023
<i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymomaJacqueline P Whitehouse, Hilary Hii, Chelsea Mayoh, et al.
Science Translational Medicine|May 20, 2016
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemiaGabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
Nature|June 17, 2020
Entanglement-based secure quantum cryptography over 1,120 kilometresJuan Yin, Yu-Huai Li, Sheng-Kai Liao, et al.
Pageof 50